8-K
Current Report
Celldex Therapeutics, Inc. Filed Acc 0001104659-19-006667
Shareholder rights changed · Bylaws or fiscal year change
- Item 3.03 Material modification to rights of security holders
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
From the SEC's structured data for this filing
Loading a19-4170_18k.htm…